Rational Design, Synthesis and Biological Evaluation of Pyrimidine-4,6-diamine derivatives as Type-II inhibitors of FLT3 Selective Against c-KIT

FMS-like Tyrosine Kinase 3 (FLT3) is a clinically validated target for acute myeloid leukemia (AML). Inhibitors targeting FLT3 have been evaluated in clinical studies and have exhibited potential to treat FLT3-driven AML. A frequent, clinical limitation is FLT3 selectivity, as concomitant inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Bharate, Jaideep B., McConnell, Nicholas, Naresh, Gunaganti, Zhang, Lingtian, Lakkaniga, Naga Rajiv, Ding, Lucky, Shah, Neil P., Frett, Brendan, Li, Hong-yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829162/
https://www.ncbi.nlm.nih.gov/pubmed/29487300
http://dx.doi.org/10.1038/s41598-018-21839-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829162/
https://www.ncbi.nlm.nih.gov/pubmed/29487300
http://dx.doi.org/10.1038/s41598-018-21839-3

Ejemplares similares